Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2.
about
Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinomaIntegrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery.Linking the ovarian cancer transcriptome and immunomePolymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium.Cytoglobin, the newest member of the globin family, functions as a tumor suppressor geneTranslation efficiency in humans: tissue specificity, global optimization and differences between developmental stages.Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples.Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cellsAn IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor responseIdentification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancerSimultaneous expression of caveolin-1 and E-cadherin in ovarian carcinoma cells stabilizes adherens junctions through inhibition of src-related kinasesMultiple signatures of a disease in potential biomarker space: Getting the signatures consensus and identification of novel biomarkers.A homeobox gene related to Drosophila distal-less promotes ovarian tumorigenicity by inducing expression of vascular endothelial growth factor and fibroblast growth factor-2The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signallingSPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells.Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcomeGene expression patterns in the histopathological classification of epithelial ovarian cancer.BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells.Variant HNF1 modulates epithelial plasticity of normal and transformed ovary cells.Differential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro.Systems biology and cancer stem cells.Evaluating cell lines as tumour models by comparison of genomic profiles.MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.Specific gene expression profiles distinguish among functional allelic variants of the mouse Pthlh gene in transfected human cancer cells.Extracellular matrix proteins and tumor angiogenesis.Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis.
P2860
Q24309898-13053356-27A7-468D-AB0D-2954D77154BDQ30914170-45D696C7-583B-4527-961A-8771955C093EQ33313203-A68FB02C-963E-4CAD-AEEF-F62E2B360B80Q33747831-5178CA77-B2FB-4935-B797-7BE64589D140Q33769833-17C80A76-04EE-4548-82D4-AACEC40D32F7Q33871232-25A67E32-0F2B-461B-8A6E-7B74495ED843Q34209814-4F213095-A6F5-43D3-B3E6-B5471C6D1DD5Q34648726-E3BD5459-337B-45FA-B14D-A3AAA90B3B75Q34868121-38F9433B-96B9-4FC0-8C98-7017EA131778Q35044404-4917C8F4-7CD4-4F06-9C60-092692DA0BBFQ35085393-DF265B22-DC65-4326-B7AC-B5C42D0E7571Q35671355-26EAD39B-5E6F-4A66-A570-B06F87D678FFQ35757194-7EDD271E-29AC-410C-93DA-FAD4C4D63450Q36038778-F272EB86-35D0-4CCF-B8EA-3F37ADB7ECB8Q36131297-F7EA3118-43C7-48D2-83D2-D7A124F9AB57Q36232027-4D832D53-BAAE-42AA-896B-E366808A528DQ36375372-56601644-6DB9-4E6B-92C1-A4F58792C1EBQ36544617-550066E2-BA9C-488A-B268-ACA0C888F1A5Q36685324-B0AA35A1-7D8F-4F39-83F7-76E0F8B18199Q36982136-21B4F20F-7D55-4629-8DE7-3F6BC864705AQ36992167-74E6C278-A57C-4F34-A514-B275F7525618Q37010408-6D75B82D-500D-404F-8E6B-E6C15EF777B5Q37025950-231E41EF-1B4C-4B0B-A478-9C1C9B2A7939Q38509951-B450A010-07B0-4ADE-B1E1-8B005D29D330Q40184776-1335107E-9607-43F8-8347-5C02C61D8D6DQ40302230-7E4A0579-3383-4969-B3E3-D7D0EFE941C5Q42699734-E1CDECB5-96A4-42E0-AF74-E46368ADF598Q53612481-D8EACFAB-EC49-4AC1-9ACB-DB8A35DE6EE5
P2860
Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Gene expression profiling of a ...... ng fibroblast growth factor 2.
@en
type
label
Gene expression profiling of a ...... ng fibroblast growth factor 2.
@en
prefLabel
Gene expression profiling of a ...... ng fibroblast growth factor 2.
@en
P2093
P2860
P50
P356
P1433
P1476
Gene expression profiling of a ...... ng fibroblast growth factor 2.
@en
P2093
Claudio Schneider
Cristina Ferrario
Domenico Delia
Erica Bussani
Fabio Turatti
Francesco Raspagliesi
James F Reid
M Stefania Lagonigro
Maria Oggionni
Norma Bertuletti
P2860
P2888
P304
P356
10.1038/SJ.ONC.1207979
P407
P50
P577
2004-10-01T00:00:00Z
P5875
P6179
1030499478